1 results match your criteria: "Division of Urogynecology Santa Casa de Sao Paulo School of Medical Sciences[Affiliation]"
A prospective randomized clinical trial comparing two doses of AbobotulinumtoxinA for idiopathic overactive bladder.
Neurourol Urodyn
February 2019
Department of Obstetrics and Gynecology, Division of Urogynecology Santa Casa de Sao Paulo School of Medical Sciences, SP, Brazil.
Aims: To compare 300 U versus 500 U of abobotulinumtoxinA (ABO) intravesical injections for the treatment of idiopathic overactive bladder (OAB) refractory to first and second-line treatments.
Methods: A prospective, randomized, single blind study was performed in female patients with symptoms of OAB, who had failed conservative treatment. Patients were treated with 300 or 500 U of ABO injected into 30 sites, avoiding the trigone.